PTEN antagonist peptide (PAP4) is a 30-amino acid peptide designed to bind the C-terminal portion of phosphatase and tensin homolog (PTEN), a neuronal-intrinsic inhibitor of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway that regulates axon growth. Through this binding interaction, PAP4 inhibits PTEN activity, thereby relieving the intrinsic suppression of axon growth capacity in neurons. The peptide is capable of crossing the blood-brain barrier, allowing for systemic delivery.

In studies using a rat model of chronic cervical contusion spinal cord injury, systemic administration of PAP4 promoted robust growth of descending bulbospinal axons originating from the rostral ventral respiratory group (rVRG) caudal to the injury site within the denervated portion of the phrenic motor neuron pool. This axon growth was associated with partial recovery of diaphragm motor activity. The growth-promoting effects of PAP4 on rVRG axons were observed specifically at locations critical for控制 of diaphragmatic respiratory function, with a five- to eight-fold increase in labeled rVRG axon profiles and total axon length compared to control conditions. The peptide's actions were attributed to its capacity to modulate neuron-intrinsic axon growth potential by targeting PTEN-mediated signaling.

• Ohtake Y, Park D, Muneer PMA, Li H, Xu B, Sharma K, Smith GM, Selzer ME, Li S. The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury. Biomaterials. 2014 May;35(16):4610-26. doi: 10.1016/j.biomaterials.2014.02.037. Epub 2014 Mar 12. PMID: 24630093; PMCID: PMC4195449.
• Michel-Flutot P, Cheng L, Thomas SJ, Lisi B, Schwartz H, Lam S, Lyttle M, Jaffe DA, Smith G, Li S, Wright MC, Lepore AC. PTEN inhibition promotes robust growth of bulbospinal respiratory axons and partial recovery of diaphragm function in a chronic model of cervical contusion spinal cord injury. Exp Neurol. 2024 Aug;378:114816. doi: 10.1016/j.expneurol.2024.114816. Epub 2024 May 22. PMID: 38789023; PMCID: PMC11200215.

三氟乙酸（Trifluoroacetic acid，简称 TFA）是高效液相色谱（简称 HPLC）纯化过程中常用的反离子。TFA 的存在可能会对肽的净重量、外观及溶解度产生影响，具体如下：

对净重量的影响：TFA 盐会增加产物的总质量。在大多数情况下，肽的含量占总重量的 80% 以上，剩余部分则为 TFA。

对溶解度的影响：TFA 盐通常能提高肽在水溶液中的溶解度。

在生物检测中的影响：对于大多数标准的体外检测，残留的 TFA 水平一般不会造成干扰。但需注意，在高灵敏度的细胞研究或生化研究中，需关注其存在可能带来的影响。

干品多肽的重量中不仅仅包含多肽，还包含有一些非肽的组份，如水、被吸收的溶剂、配位离子和盐等。肽的净含量是指肽在其中的重量百分比，这个百分比的数值范围很大，可能从50%到90%，取决于纯度、序列以及合成和纯化的方法，不要将肽的净含量和肽的纯度混为一谈，他们是两个完全不同的概念。纯度通常是通过HPLC测定的。纯度定义的是多肽样品中含正确序列的组分的百分比，而肽的净含量是指样品中肽类物质相对于总物质所占的百分比，肽的净含量通常是氨基酸组分分析或紫外分光法测定的，这个信息主要是在一些对肽的浓度很敏感的实验中，对计算肽的浓度是很重要的。